Cargando…

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease

The overlapping clinical features of relapsing remitting multiple sclerosis (RRMS), aquaporin-4 (AQP4)-antibody (Ab) neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein (MOG)-Ab disease mean that detection of disease specific serum antibodies is the gold standard...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jurynczyk, Maciej, Probert, Fay, Yeo, Tianrong, Tackley, George, Claridge, Tim D. W., Cavey, Ana, Woodhall, Mark R., Arora, Siddharth, Winkler, Torsten, Schiffer, Eric, Vincent, Angela, DeLuca, Gabriele, Sibson, Nicola R., Isabel Leite, M., Waters, Patrick, Anthony, Daniel C., Palace, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718082/ https://www.ncbi.nlm.nih.gov/pubmed/29208041 http://dx.doi.org/10.1186/s40478-017-0495-8

Ejemplares similares

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
por: Yeo, Tianrong, et al.
Publicado: (2019)

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
por: Messina, Silvia, et al.
Publicado: (2021)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
por: Yeo, Tianrong, et al.
Publicado: (2020)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
por: Waters, Patrick, et al.
Publicado: (2015)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
por: Morris, Katrina A., et al.
Publicado: (2015)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
por: Zhou, Lin, et al.
Publicado: (2022)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
por: Hyun, Jae-Won, et al.
Publicado: (2020)

No strong HLA association with MOG antibody disease in the UK population
por: Grant‐Peters, Melissa, et al.
Publicado: (2021)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
por: Sun, Chuan-bin
Publicado: (2023)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO
por: Kitley, Joanna, et al.
Publicado: (2015)

Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
por: Duan, Yunyun, et al.
Publicado: (2021)

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging
por: Cortese, Rosa, et al.
Publicado: (2023)

Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease
por: Camera, Valentina, et al.
Publicado: (2023)

Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders
por: García-Miranda, Pablo, et al.
Publicado: (2019)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

Neurological update: MOG antibody disease
por: Wynford-Thomas, Ray, et al.
Publicado: (2018)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
por: Prain, Kerri, et al.
Publicado: (2019)

Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach
por: Yeo, Tianrong, et al.
Publicado: (2021)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
por: Bollo, Luca, et al.
Publicado: (2021)

Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands
por: Probert, Fay, et al.
Publicado: (2022)

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
por: Probert, Fay, et al.
Publicado: (2021)

Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands
por: Probert, Fay, et al.
Publicado: (2022)

Understanding MOG antibody-associated disease in Brazil
por: Callegaro, Dagoberto, et al.
Publicado: (2023)

A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application
por: Yeo, Tianrong, et al.
Publicado: (2020)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Antigen-specific immunotherapy for MOG antibody-associated diseases
por: Nessler, Stefan
Publicado: (2019)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
por: Mori, Sotaro, et al.
Publicado: (2020)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pcnje43ge4p1i9r3dissei8dpo